Abstract: A motor assembly includes a working part, a synchronous motor having a shaft, and a mechanical coupling joining the working part to the motor. The coupling has two driving teeth fixed relative to the shaft, two driven teeth fixed relative to the working part, and two middle members. The coupling provides a predetermined range of angular movement between the motor and the working part. The middle members are circumferentially distributed between the two driving teeth and between the two driven teeth, thereby each of the middle members is movable by the driving teeth to contact the driven teeth and provides an interference between a driving tooth and a driven tooth to drive the working part.

Abstract: In one aspect of the present invention, an LCD includes a front frame having a flange and a rear cover having a flange defining a housing therebetween, a liquid crystal (LC) panel placed in the housing, a backlight positioned between the LC panel and the rear cover, and a backlight frame having a first engaging structure configured to receive the flanges of the front frame and the rear cover, and a second engaging structure configured to retain the backlight and the LC panel in the housing.

Abstract: A patient lift apparatus designed to lift and transfer patients is provided. The patient lift apparatus includes a patient lift base and a modular patient support device removably connected to the patient lift base to support a patient. The patient lift base includes a cantilever element, a portal frame, three wheel assemblies, a hanging mechanism. The cantilever element is pivoted intersectionally with the portal frame. The three wheel assemblies are disposed at the bases of the cantilever element and the portal frame, as three bearing points. The hanging mechanism is pivoted to the top of the cantilever element and connected to the modular patient support device below. When the cantilever element and the portal frame are rotated relatively, the height, the shape and the positions of the bearing points of the patient lift apparatus are changed accordingly.

Abstract: A coupling structure for connecting an impeller to a motor shaft of a liquid pump, includes a carrier rod sleeved on the shaft, and a seal assembly connecting the carrier rod to a housing of the pump. The carrier rod is fixed to the shaft by way of a screw thread structure. The seal assembly includes a rotating seal sealingly fixed on an outer surface of the carrier rod and fixed to the carrier rod for rotation there with by an interlocking structure.

Abstract: Methods for fabricating electrode structures on a substrate are presented. The fabrication method includes providing a substrate with a patterned metal layer thereon, defining an electrode area. A passivation glue is formed on the patterned metal layer. An electrode layer is formed in the electrode area. A filling process is performed to deposit nano metal oxides on the electrode layer to extensively fill the entire electrode area.

Abstract: A backlight module and a method for manufacturing a base thereof are provided. The backlight module base includes a back plate and a frame. The back plate has a plate body and at least one sidewall, which includes a wall body and a folding structure bending from the top of the wall body. The folding structure, the plate body, and the wall body together enclose a groove. The frame is formed on the plate body and adjacent to an inner surface of the sidewall. A part of the frame is embedded into the groove. The engagement between the frame and the groove increases the contact area between the frame and the back plate to improve the connection strength. In addition, the folding design of the sidewall increases the rigidity of the whole structure.

Abstract: Biomarkers for liver diseases and method for using the same are provided. For detecting liver cirrhosis and liver cancer, the biomarkers are selected from any one of the amino acid sequences with SEQ ID NO:1 to SEQ ID NO:24 or derivatives or fragments or variants or the combination thereof or the antibodies against the amino acid sequences. Then the biomarkers are further developed into detection kits, such that by detecting the existence of autoantibodies or autoantigens in screened specimens, liver diseases are detected with higher accuracy and sensitivity.

Abstract: A digital photo frame with photographing function includes a digital frame, a lens module, a bracket, and a copy stand. The digital frame may further include a display module, a frame, a memory module, a control module, an input module, a power supply module, and a sense module. The display module is framed within the frame, and the lens module is disposed at a predetermined location on the frame. A paper photo can be disposed on the copy stand that is pivotally connected to the bracket. The input module can input a control signal to operate and control the lens module to copy photograph the paper photo into a digital photo and store the digital photo in the memory module and further display the digital photo on the display module.

Abstract: A method for measuring lens quality includes receiving and transmitting an image's information to a location module through an image collecting module. A location module partitions the image's information into a plurality of measure areas. An image processing module computes the Modulation Transfer Function (MTF) of each measure area. A comparing module compares the MTF with a predetermined MTF to determine quality of the lenses.

Abstract: A system includes a portable electronic device and a web page printing module installed in the portable electronic device. The portable electronic device has an embedded operating system and a web browser for presenting a web page. The web page printing module is capable of converting the web page to a picture format file and then converting the picture format file to a print (PRN) file which is printable by a printer. A printing method associated with above described system is also disclosed.

Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.

Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.

Abstract: A method for autonomous monitoring includes the following steps. A plurality of video signals of a region to be monitored is collected by a video signal collecting module. A current image and a previous image of the region to be monitored are analyzed by an image processing module. A number of points of difference between the current image and the previous image is calculated by an image comparison module. The image comparison module stores a predetermined threshold value of different points and is capable of outputting an alarm signal when the number of different points exceeds the predetermined threshold value. An alarm condition is indicated by an alarm module when the alarm signal is received.

Abstract: Biomarkers for liver diseases and method for using the same are provided. For detecting liver cirrhosis and liver cancer, the biomarkers are selected from any one of the amino acid sequences with SEQ ID NO:1 to SEQ ID NO:24 or derivatives or fragments or variants or the combination thereof or the antibodies against the amino acid sequences. Then the biomarkers are further developed into detection kits, such that by detecting the existence of autoantibodies or autoantigens in screened specimens, liver diseases are detected with higher accuracy and sensitivity.

Abstract: The present invention relates to methods of diagnosing myasthenia gravis in a subject, by determining an amount of at least one autoantibody that specifically binds one or more autoantigens selected from heat-shock protein 60 (hsp60), heat-shock protein 90, alpha isoform (hsp90?), and heat-shock protein 90, beta isoform (hsp90?). The invention also provides diagnostic kits for identifying a subject having myasthenia gravis.

Abstract: A dye-sensitizing solar cell (DSSC) is provided. The DSSC includes a working electrode, a counter electrode disposed opposite to the working electrode, a first gap control layer disposed between the working electrode and the counter electrode, a packaging material, and an electrolyte. The working electrode has a first patterned conductive line. The counter electrode has a second patterned conductive line. The first gap control layer is located on at least an outer portion of one of the first and the second patterned conductive lines to surround at least the first and the second patterned conductive lines or is symmetrically located on one of the first and the second patterned conductive lines. The packaging material is disposed on the first gap control layer such that the working electrode, the counter electrode, the first gap control layer, and the packaging material form a gap. The electrolyte is disposed in the gap.

Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.

Abstract: The present invention relates to transgenic plants comprising a plurality of nucleic acids heterologous to said plant, each of said nucleic acid comprising a coding sequence operably linked to one or more regulatory elements for directing expression of said coding sequence in said plant, said nucleic acid being stably integrated at or adjacent to rDNA sequences, or a seed, organ, tissue, part or cell thereof, or a descendant of said plant, seed, organ, tissue, part or cell; methods of producing the transgenic plants; and methods of producing oil using the transgenic plants.

Abstract: The present invention relates to transgenic plant cell cultures comprising transgenic plant cells comprising a plurality of nucleic acids heterologous to said plant, each of said nucleic acids comprising a coding sequence encoding a pharmaceutical product of interest operably linked to one or more regulatory elements for directing expression of said coding sequence in said plant cell, said nucleic acids being stably integrated at or adjacent to native rDNA of said plant cell; methods of producing the transgenic plant cell culture; and methods of producing a pharmaceutical product of interest using the transgenic plant cell culture.

Abstract: A printing system includes a printer and a printer server connected to the printer. The printer server is installed with a printer driver for driving the printer. The printer server includes a web control module and a print module. The control module provides a user interface (UI) to a connected client. The control module is capable of receiving a first file in an original format from the client and transmitting the first file to the print module. The print module is capable of transforming the first file in the original format to a second file in a format printable by the printer.